| Literature DB >> 35403571 |
Furong Nie1, Jingfeng Zhang1, Mengyun Li1, Xuanniu Chang1, Haitao Duan1, Haoyan Li2, Jia Zhou1, Yudan Ji1, Liangxing Guo1.
Abstract
The LaSota strain of Newcastle disease virus (NDV) is a commonly used vaccine to control Newcastle disease. However, improper immunization is a common reason for vaccine failure. Hence, it is imperative to thoroughly explore innate immunity-related molecular regulatory responses to the LaSota vaccine. In this text, 140 long non-coding RNAs (lncRNAs), 8 microRNAs (miRNAs), and 1514 mRNAs were identified to be differentially expressed by RNA sequencing analysis in the thymic tissues of Chinese Partridge Shank chickens after LaSota vaccine inoculation. Moreover, 70 dysregulated genes related to innate immunity were identified based on GO, Reactome pathway, and InnateDB annotations and differential expression analysis. Additionally, dysregulated lncRNAs and innate immunity-related mRNAs that could interact with dysregulated miRNAs were identified based on bioinformatics prediction analysis via the miRanda software and differential expression analysis. Among these transcripts, expression patterns of five lncRNAs, seven miRNAs, and six mRNAs were further examined by RT-qPCR assay. Both RNA-seq and RT-qPCR outcomes showed that 10 transcripts (MSTRG.22689.1, ENSGALT00000065826, ENSGALT00000059336, ENSGALT00000060887, gga-miR-6575-5p, gga-miR-6631-5p, gga-miR-1727, paraoxonase 2 (PON2), mitogen-activated protein kinase 10, and cystic fibrosis transmembrane conductance regulator (CFTR) were highly expressed, and 4 transcripts (MSTRG.188121.10, gga-miR-6655-5p, gga-miR-6548-3p, and matrix metallopeptidase 9 (MMP9) were low expressed after NDV infection. Additionally, two potential competing endogenous RNA networks (ENSGALT00000060887/gga-miR-6575-5p/PON2 or MSTRG.188121.10/gga-miR-6631-5p/MMP9) and some co-expression axes (ENSGALT00000065826/gga-miR-6631-5p, MSTRG.188121.10/gga-miR-6575-5p, MSTRG.188121.10/CFTR, ENSGALT00000060887/MMP9) were identified based on RT-qPCR and co-expression analyses. In conclusion, we identified multiple dysregulated lncRNAs, miRNAs, and mRNAs after LaSota infection and some potential regulatory networks for these dysregulated transcripts.Entities:
Keywords: LaSota; Newcastle disease; Newcastle disease virus; RNA sequencing; innate immune; lncRNA; mRNA; microRNA
Mesh:
Substances:
Year: 2022 PMID: 35403571 PMCID: PMC9161911 DOI: 10.1080/21655979.2021.2008737
Source DB: PubMed Journal: Bioengineered ISSN: 2165-5979 Impact factor: 6.832
Reference genome information
| Genome | Gallus_gallus.Gallus_gallus-5.0.dna.toplevel.fa |
| genebuild by | Ensembl |
| Database version | 94.5 |
| Base Pairs | 1,285,637,921 |
Chicken gene annotation information in different databases
| Database | Number | Percentage |
|---|---|---|
| NCBI_GI | 12312 | 67.1 |
| eggNOG | 1158 | 6.31 |
| KEGG | 9014 | 49.13 |
| GO | 15747 | 85.83 |
| EC | 2675 | 14.58 |
| UniProtID | 8761 | 47.75 |
| Ensembl | 18,346 | 100 |
Raw data statistics
| Sample | Reads No. | Bases (bp) | Q30 (bp) | N (%) | Q20 (%) | Q30 (%) |
|---|---|---|---|---|---|---|
| ctl1 | 112,006,994 | 16,913,056,094 | 15,556,184,034 | 0.016238 | 96.64 | 91.97 |
| ctl2 | 107,861,238 | 16,287,046,938 | 14,921,050,839 | 0.010633 | 96.46 | 91.61 |
| ctl3 | 101,546,874 | 15,333,577,974 | 14,003,424,760 | 0.005531 | 96.26 | 91.32 |
| 48h1 | 108,620,036 | 16,401,625,436 | 15,386,850,552 | 0.002824 | 97.37 | 93.81 |
| 48h2 | 106,833,502 | 16,131,858,802 | 15,119,130,773 | 0.002845 | 97.34 | 93.72 |
| 48h3 | 101,846,738 | 15,378,857,438 | 14,396,829,696 | 0.002809 | 97.26 | 93.61 |
Note:
Bases (bp): Total number of bases.
Q30 (bp): Base number of base recognition accuracy rate > 99.9%.
N (%): Percentage of ambiguous bases.
Q20 (%): Percentage of bases with recognition accuracy rate > 99%.
Q20 (%): Percentage of bases with recognition accuracy rate > 99.9%.
RNAseq Map statistics
| Sample | Clean_Reads | Total_Mapped | Multiple_Mapped | Uniquely_Mapped |
|---|---|---|---|---|
| ctl1 | 111,188,706 | 90,835,667 (81.70%) | 3,410,734 (3.75%) | 87,424,933 (96.25%) |
| ctl2 | 106,983,056 | 87,490,661 (81.78%) | 3,258,412 (3.72%) | 84,232,249 (96.28%) |
| ctl3 | 100,626,522 | 80,628,531 (80.13%) | 3,009,815 (3.73%) | 77,618,716 (96.27%) |
| 48h1 | 108,187,642 | 88,886,144 (82.16%) | 3,497,429 (3.93%) | 85,388,715 (96.07%) |
| 48h2 | 106,428,002 | 87,593,246 (82.30%) | 3,605,116 (4.12%) | 83,988,130 (95.88%) |
| 48h3 | 101,429,340 | 82,519,425 (81.36%) | 3,459,058 (4.19%) | 79,060,367 (95.81%) |
Note:
Clean Reads No.: total number of aligned sequences
Total Mapped: sequence number aligned to reference genome, percentage: Total Mapped number/Clean Read number
Multiple Mapped: sequence number aligned to multiple positions, percentage: Multiple Mapped number/Total Mapped number
Uniquely Mapped: sequence number aligned to one position, percentage: Uniquely Mapped number/Total Mapped number
Reverse-transcription primers for miRNAs (stem-loop primers)
| gga-miR-6631-5p | 5’-CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGgcagaacc-3’ |
| gga-miR-6655-5p | 5’-CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGaggataca-3’ |
| gga-miR-6575-5p | 5’-CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGaagagctt-3’ |
| gga-miR-6548-3p | 5’-CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGacagcaac-3’ |
| gga-miR-1744-3p | 5’-CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGtcagtctt-3’ |
| gga-miR-1727 | 5’-CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGccttcagt-3’ |
| gga-miR-1712-3p | 5’-CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGccaaactc-3’ |
Quantitative PCR primers
| miRNAs | Forward primers | Reverse primers |
|---|---|---|
| gga-miR-6631-5p | 5’-ACACTCCAGCTGGGGAAGAGAATGCTGTGG-3’ | 5’-TGGTGTCGTGGAGTCG-3’ |
| gga-miR-6655-5p | 5’-ACACTCCAGCTGGGTCTGCTAGGAGGCTGTG-3’ | 5’-TGGTGTCGTGGAGTCG-3’ |
| gga-miR-6575-5p | 5’-ACACTCCAGCTGGGTTGTCAGCTTGGGGAA-3’ | 5’-TGGTGTCGTGGAGTCG-3’ |
| gga-miR-6548-3p | 5’-ACACTCCAGCTGGGAGAGGTGCCCCGCTGT-3’ | 5’-TGGTGTCGTGGAGTCG-3’ |
| gga-miR-1744-3p | 5’-ACACTCCAGCTGGGACTTCAACAGGAGCAA-3’ | 5’-TGGTGTCGTGGAGTCG-3’ |
| gga-miR-1727 | 5’-ACACTCCAGCTGGGAAGCTGCTCTAATGAAC-3’ | 5’-TGGTGTCGTGGAGTCG-3’ |
| gga-miR-1712-3p | 5’-ACACTCCAGCTGGGTTCAGTTATCAGTGGA-3’ | 5’-TGGTGTCGTGGAGTCG-3’ |
| mRNAs | forward primers | reverse primers |
| ENSGALG00000009689 (PON2) | 5’-CCTCATGGGATCAGCACTTAC-3’ | 5’-CACTTGTCAGAAGGTCGTGTC-3’ |
| ENSGALG00000003045 (E2F1) | 5’-CACCACAGCCACAGGATTAC-3’ | 5’-GAAGTCCCCAAAGTCACAGTC-3’ |
| ENSGALG00000032986 (CFTR) | 5’-GGGGAGGTCACCAAATCTGT-3’ | 5’-AGGGTGTATGAGCAGCGTTC-3’ |
| ENSGALG00000011109 (MAPK10) | 5’-TACAGCGTGGAAGTGGGTGA-3’ | 5’-GCACAAACTATTCCCTGAGCC-3’ |
| ENSGALG00000006992 (MMP9) | 5’-CCACTCGTCCTTCTGGAAATC-3’ | 5’-CCCTCTTGGTGAGCACATCTT-3’ |
| ENSGALG00000005653 (NF-κB2) | 5’-AGCAGTGGGAACTTCACTCTG-3’ | 5’-TCGTCGTCCTCATAGAACCG-3’ |
| lncRNAs | forward primers | reverse primers |
| MSTRG.188121.10 | 5’-AGACGTTACAGCAACCTGGG-3’ | 5’-AGTCCTTGGACTGAGCAACG-3’ |
| ENSGALT00000065826 | 5’-GACAGGACGTTTGCTCCTCA-3’ | 5’-CTTCTCCCCCACATAACGCA-3’ |
| ENSGALT00000059336 | 5’-GGAGAAGACGGGCATTTCCT-3’ | 5’-TTAGACCGTTTTGCCCCCAG-3’ |
| ENSGALT00000060887 | 5’-CGGAAAGTGTCGTTGCAGTC-3’ | 5’-AGAGCAGACGCATCTGAAGG-3’ |
| MSTRG.22689.1 | 5’-GTTCCAGGCATCTCGGGTTT-3’ | 5’-AATCAGGCTTGCCACCATACT-3’ |
Figure 1.The MA plots of differentially expressed lncRNAs in the vaccine-treated group vs the control group.
Figure 2.Interaction and enrichment analysis of filtered dysregulated innate immune genes. (a) Interaction network of proteins encoded by filtered dysregulated innate immune genes. The confidence score was equal to or higher than 0.4. (b) The top 20 KEGG pathways enriched by the dysregulated innate immune genes. (c) The top 20 GO_biological_process terms enriched by the dysregulated innate immune genes.
Figure 3.The network of differentially expressed lncRNAs, miRNAs and innate immune genes. The networks were drawn using the Cytoscape software.
Figure 4.RT-qPCR validation of some differentially expressed lncRNAs, miRNAs and mRNAs. (a-c) Expression levels of several lncRNAs (MSTRG.22689.1, ENSGALT00000065826, ENSGALT00000059336, ENSGALT00000060887 and MSTRG.188121.10) (a), miRNAs (gga-miR-1744-3p, gga-miR-1712-3p gga-miR-6575-5p, gga-miR-6631-5p, gga-miR-1727, gga-miR-6655-5p and gga-miR-6548-3p) (b) and mRNAs (PON2, MAPK10, CFTR, MMP9, E2F1, and NF-κB2) (c) were further examined through RT-qPCR assay in thymic tissue samples of 10 random chickens at 0 h and 48 h post NDV injection. Note: paraoxonase 2 (PON2), mitogen-activated protein kinase 10 (MAPK10), E2F transcription factor 1 (E2F1), cystic fibrosis transmembrane conductance regulator (CFTR), matrix metallopeptidase 9 (MMP9), nuclear factor kappa B subunit 2 (NF-κB2).
Figure 5.Pearson correlation analysis of differentially expressed lncRNAs, miRNAs and mRNAs in thymic tissue samples of 10 random chickens at 48 h after NDV inoculation. Note: matrix metallopeptidase 9 (MMP9), cystic fibrosis transmembrane conductance regulator (CFTR), paraoxonase 2 (PON2).